HemaSphere Podcast
By HemaSphere Journal
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by HemaSphere Journal
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 28
Description
HemaSphere is the official online, open access journal of the European Hematology Association (EHA). HemaSphere publishes exciting basic, translational, and clinical research in hematology. We are pleased to introduce our new podcast series where our host and guest speakers exchange ideas about select HemaSphere publications. Spend some time with us and enjoy casual and insightful discussions about hematology research. Listen to the stories behind the papers. HemaSphere is always accessible; our full range of open access publications is available at www.hemaspherejournal.com.
| Episode | Date |
|---|---|
|
Why Inflammatory Signaling Holds the Key to Durable MDS Therapies - Dr Manja Wobus, Dr Katja Sockel
|
Jun 17, 2026 |
|
p53 in Cancer: Dual Threat - Dr Isabelle Plo, Dr Barbara Monte-Mór
|
May 07, 2026 |
|
Blinatumomab in De Novo AYA ALL - Dr Matthew Greenwood
|
Feb 09, 2026 |
|
Inequalities in sickle cell therapies - Dr Stephen Hibbs, Dr Paul Telfer, Mary-Shaniqua - Patient Advocate
|
Dec 02, 2025 |
|
Defining Lineage in Ambiguous Leukemia: A Transcriptomic View - Dr. Anikó Sijs-Szabó & Roger Mulet Lázaro, PhD
|
Nov 03, 2025 |
|
EHA/EBMT Survey on Grading and Management of ICAHT - Dr Kai Rejeski
|
Oct 01, 2025 |
|
Tackling NUP98 Rearranged AML in Pediatric Oncology - Prof Michel Zwaan, Prof Olaf Heidenreich
|
Sep 01, 2025 |
|
Part 2 - Metabolism in hematology - Ep 3.4
|
Jul 29, 2025 |
|
Part 1 - Metabolism in hematology - Ep 3.4
|
Jul 29, 2025 |
|
Machine learning for AML-MRD - Ep 3.3
|
Jul 02, 2025 |
|
2 of 2: Navigating Neutropenia: New Guidelines Explained - Ep 3.2
|
Jun 03, 2025 |
|
Single‐cell DNA and surface protein - Ep 3.1
|
May 05, 2025 |
|
Two distinct fetal-type signatures characterize JMML - Ep 2.8
|
Apr 02, 2025 |
|
Revolutionizing Pediatric Cancer Research with PDXs - Ep 2.7
|
Feb 05, 2025 |
|
High 5hmC predicts worse OS - Ep 2.6
|
Jan 07, 2025 |
|
Informed consent is almost impossible - Ep 2.5
|
Nov 27, 2024 |
|
Best of Pediatric Hematology from EHA2024 - Ep 2.4
|
Oct 25, 2024 |
|
NOTCH1 fusions in T‐LBL - Ep 2.3
|
Oct 03, 2024 |
|
A transcriptional cofactor‐mediated dependency module - Ep 2.2
|
Jul 29, 2024 |
|
Unraveling the secrets of thrombopoiesis - Ep 2.1
|
Jul 02, 2024 |
|
What’s so Great About the P-value? A Statistician’s Point of View - Ep 1.8
|
Dec 06, 2023 |
|
This Is Going to Hurt: Revisiting the Patient Experience of Bone Marrow Biopsies - Ep 1.7
|
Nov 02, 2023 |
|
1 of 2: The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children - Ep 1.6
|
Oct 04, 2023 |
|
Part 1 - Comprehensive Diagnosis and Management of POEMS Syndrome - Ep 1.4
|
Sep 06, 2023 |
|
Part 2 - Comprehensive Diagnosis and Management of POEMS Syndrome - Ep 1.5
|
Sep 06, 2023 |
|
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis - Ep 1.3
|
Aug 02, 2023 |
|
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer - Ep 1.2
|
Jul 06, 2023 |
|
Long COVID-19” of Researchers: What to Do Next? - Ep 1.1
|
Jun 08, 2023 |